This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
- Alice Nguyen
- Akita Joshi
- Samantha Trinh
- Sara Taylor1
- ↵* Corresponding author; email: sataylor{at}tarleton.edu
Abstract
OBJECTIVE: This case study outlines the diagnostic schema employed at our facility to accurately identify a patient's hematological condition to facilitate optimal treatment. BACKGROUND: A 71 year old male patient presented to our hospital with complete blood count (CBC) data that was suggestive of a lymphoid malignancy due to a critically low leukocyte count coupled with a predominance of lymphocytes displaying abnormal morphology. METHOD: Immunophenotyping studies carried out on the bone marrow indicated that the patient had a B lymphocyte malignancy, although a T cell neoplasm could not be ruled out. Karyotyping on this patient revealed a complex karyotype which supported the conclusion that this patient suffered from a malignant condition. Finally, molecular diagnostics testing was employed to specifically identify the disease state. CONCLUSION: While the testing results are suggestive of a lymphoid malignancy, the patient's diagnosis remains unclearly defined.
- Received February 18, 2018.
- Accepted February 18, 2018.
- Published by American Society for Clinical Laboratory Science
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.